Navigation Links
John J. Young, Jr. Joins SRI Board of Directors
Date:9/18/2009

MENLO PARK, Calif., Sept. 18 /PRNewswire/ -- SRI International, an independent, nonprofit research and development institute, announced today that John J. Young, Jr. has been elected to SRI's Board of Directors, effective September 1, 2009. Young will become the SRI Board's tenth member, joining a group that includes leaders from government, academia, and the business community.

"Throughout his career, John has been a champion of innovative and efficient business practices that respond to critical needs," said Samuel Armacost, SRI's Chairman of the Board. "We are very pleased to welcome John to SRI's Board of Directors and look forward to the important contributions he will make towards SRI's continued growth as a client-focused R&D organization."

Mr. Young recently completed service as the Undersecretary of Defense for Acquisition, Technology, and Logistics, overseeing a $200 billion budget focused on research, development, procurement, and logistics programs. He previously served as the Director of Defense Research and Engineering (DDR&E) and as the Assistant Secretary of the Navy for Research, Development, and Acquisition. In that role, Young was able to increase the effectiveness and efficiency of Navy and Marine Corps procurement and research programs and to control costs.

Mr. Young's earlier experience includes ten years as a senior staff member with the U.S. Senate Defense Appropriations Subcommittee.

While at the Defense Department, Young received Distinguished Civilian Service awards from the Department of Defense, Joint Chiefs of Staff, and Army. He also received a Distinguished Public Service award from the Department of the Navy.

Mr. Young has a Master's degree in Aeronautics and Astronautics from Stanford University and a Bachelor's degree in Aerospace Engineering from the Georgia Institute of Technology.

About SRI International

Silicon Valley-based SRI International is one of the world's leading independent research and technology development organizations. SRI, which was founded by Stanford University as Stanford Research Institute in 1946 and became independent in 1970, has been meeting the strategic needs of clients and partners for more than 60 years. Perhaps best known for its invention of the computer mouse and interactive computing, SRI has also been responsible for major advances in networking and communications, robotics, drug discovery and development, advanced materials, atmospheric research, education research, economic development, national security, and more. The nonprofit institute performs sponsored research and development for government agencies, businesses, and foundations. SRI also licenses its technologies, forms strategic alliances, and creates spin-off companies. In 2008, SRI's consolidated revenues, including its wholly owned for-profit subsidiary, Sarnoff Corporation, were approximately $490 million.


'/>"/>
SOURCE SRI International
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Accumetrics Appoints John J. Young, MD Chief Medical Officer
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , February 17, 2017 ... "Biomarkers Market by Product (Consumables, Service), Type (Safety, ... (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - ... market is projected to reach USD 53.34 Billion ... growing at a CAGR of 13.8% during the ...
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
Breaking Biology Technology:
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
Breaking Biology News(10 mins):